SYS ONLINE
Supplements/Amino Acid

DL-Phenylalanine (DLPA)

Racemic phenylalanine for pain and mood.

Buy

Overview

Racemic phenylalanine for pain and mood.

Natural sources
  • Dietary protein from animal sources (meat, fish, eggs, dairy) and plant sources (soy, legumes, grains)
  • Free-form amino acid powders and capsules
  • Targeted pre-workout, recovery, or sleep formulations
Common forms
  • Free-form crystalline powder
  • Capsules or tablets
  • Pre-mixed recovery or hydration beverages
  • Time-release formulations

Mechanism of action

D-isomer inhibits enkephalinase; L-isomer is catecholamine precursor.

Pathways
  • · D-isomer inhibits enkephalinase
  • · L-isomer is catecholamine precursor

Effects on the body

Supports
May reduce chronic pain

Organ system effects

Brain & CNS

DL-Phenylalanine (DLPA) modulates monoaminergic and GABAergic tone relevant to mood and anxiety regulation.

Evidence-based benefits

May reduce chronic pain

Moderate evidence

Potential side effects

Common
  • · Headache
  • · Anxiety
Rare
    Serious

      Drug interactions

      Prescription medications (general)
      Always disclose DL-Phenylalanine (DLPA) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
      minor

      Supplement interactions

      Pairs well with
      • A high-quality multivitamin
        Covers micronutrient cofactors that support most supplement pathways.
      • Omega-3 (EPA/DHA)
        Foundational anti-inflammatory support that complements most regimens.
      Avoid combining with

      No specific avoidances listed.

      Dosing & bioavailability

      Typical dose
      500–1500 mg
      Best form
      Most evidence is based on the free-form crystalline powder form.
      Timing
      Consistent daily timing recommended; split larger doses if GI tolerance is a concern.
      With food?
      Either with or without food.

      Where to buy

      Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.

      Scientific evidence8Show studies
      RCTArch Phys Med Rehabil · 1986

      DLPA in chronic pain

      Walsh NE, et al.

      30 chronic pain patients

      Key findings

      Mixed results vs placebo.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: DL-Phenylalanine (DLPA) — May reduce chronic pain

      Live PubMed search

      Live results for "DL-Phenylalanine (DLPA) May reduce chronic pain" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "May reduce chronic pain". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: DL-Phenylalanine (DLPA) — randomized controlled trial

      Live PubMed search

      Live results for "DL-Phenylalanine (DLPA) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: DL-Phenylalanine (DLPA) — meta-analysis

      Live PubMed search

      Live results for "DL-Phenylalanine (DLPA) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: DL-Phenylalanine (DLPA) — pharmacokinetics

      Live PubMed search

      Live results for "DL-Phenylalanine (DLPA) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: DL-Phenylalanine (DLPA) — safety adverse events

      Live PubMed search

      Live results for "DL-Phenylalanine (DLPA) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewPubMed (NLM) · 1970

      PubMed: DL-Phenylalanine (DLPA) — dose response

      Live PubMed search

      Live results for "DL-Phenylalanine (DLPA) dose response" across the PubMed/MEDLINE peer-reviewed index.

      Key findings

      Opens current human and preclinical literature matching DL-Phenylalanine (DLPA) and "dose response". Filter by RCT, meta-analysis, or year on the results page.

      Open study
      Systematic reviewGoogle Scholar · 1970

      Google Scholar: DL-Phenylalanine (DLPA) — clinical evidence

      Live Scholar search

      Cross-database citation index for DL-Phenylalanine (DLPA) as it relates to "clinical evidence".

      Key findings

      Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.

      Open study
      Educational use only. This profile is not medical advice. Consult a qualified healthcare professional before starting any supplement, especially if you take prescription medication or have a chronic condition.

      Community discussion

      (0 threads)

      Share your experience or read what others have tried. Anecdotes are not medical advice.

      Sign in or create a free account to post or reply.
      Loading discussion…